OBJECTIVE: The aim of this study is to investigate whether the quality of the Dutch, community based, universal newborn hearing screening programme is consistent over time. DESIGN: Universal newborn hearing screening data from three cohorts are compared on a number of quality targets concerning the outcome of the screening and the process of the screening in a three stage, community based, hearing screening programme. STUDY SAMPLE: A total of 552 820 children entered the study (189 794 in 2002-2006; 181 574 in 2008, and 181 452 in 2009). RESULTS: Participation in the programme is high from implementation onwards and increases over time for all screen stages to percentages above 99%. Refer rates are within quality targets and they are consistent over time. The screening is completed within 42 days of birth for 91.5% of the children in the last cohort. Of all children screened, 0.29% to 0.30% are referred to a speech and hearing centre. Participation in diagnostic testing is 93.3% to 95.2%. Of all referred children 77% to 85% receive a diagnosis within 122 days of birth. CONCLUSIONS: A good quality neonatal hearing screening programme in youth health care has been established in the Netherlands. However, both participation in diagnostic testing after a positive screen result and the timing of the diagnostic testing can still be improved.
OBJECTIVE: The aim of this study is to investigate whether the quality of the Dutch, community based, universal newborn hearing screening programme is consistent over time. DESIGN: Universal newborn hearing screening data from three cohorts are compared on a number of quality targets concerning the outcome of the screening and the process of the screening in a three stage, community based, hearing screening programme. STUDY SAMPLE: A total of 552 820 children entered the study (189 794 in 2002-2006; 181 574 in 2008, and 181 452 in 2009). RESULTS: Participation in the programme is high from implementation onwards and increases over time for all screen stages to percentages above 99%. Refer rates are within quality targets and they are consistent over time. The screening is completed within 42 days of birth for 91.5% of the children in the last cohort. Of all children screened, 0.29% to 0.30% are referred to a speech and hearing centre. Participation in diagnostic testing is 93.3% to 95.2%. Of all referred children 77% to 85% receive a diagnosis within 122 days of birth. CONCLUSIONS: A good quality neonatal hearing screening programme in youth health care has been established in the Netherlands. However, both participation in diagnostic testing after a positive screen result and the timing of the diagnostic testing can still be improved.
Authors: Carlijn M P le Clercq; Gijs van Ingen; Liesbet Ruytjens; André Goedegebure; Henriette A Moll; Hein Raat; Vincent W V Jaddoe; Rob J Baatenburg de Jong; Marc P van der Schroeff Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-09-01 Impact factor: 6.223
Authors: Jeroen J Smits; Suzanne E de Bruijn; Cornelis P Lanting; Jaap Oostrik; Luke O'Gorman; Tuomo Mantere; Frans P M Cremers; Susanne Roosing; Helger G Yntema; Erik de Vrieze; Ronny Derks; Alexander Hoischen; Sjoert A H Pegge; Kornelia Neveling; Ronald J E Pennings; Hannie Kremer Journal: Hum Genet Date: 2021-08-19 Impact factor: 5.881
Authors: Mieke Wesdorp; Silvia Murillo-Cuesta; Theo Peters; Adelaida M Celaya; Anne Oonk; Margit Schraders; Jaap Oostrik; Elena Gomez-Rosas; Andy J Beynon; Bas P Hartel; Kees Okkersen; Hans J P M Koenen; Jack Weeda; Stefan Lelieveld; Nicol C Voermans; Irma Joosten; Carel B Hoyng; Peter Lichtner; Henricus P M Kunst; Ilse Feenstra; Suzanne E de Bruijn; Ronald J C Admiraal; Helger G Yntema; Erwin van Wijk; Ignacio Del Castillo; Pau Serra; Isabel Varela-Nieto; Ronald J E Pennings; Hannie Kremer Journal: Am J Hum Genet Date: 2018-06-28 Impact factor: 11.025
Authors: Tingfang Chen; Alex M Rohacek; Matthew Caporizzo; Amir Nankali; Jeroen J Smits; Jaap Oostrik; Cornelis P Lanting; Erdi Kücük; Christian Gilissen; Jiddeke M van de Kamp; Ronald J E Pennings; Staci M Rakowiecki; Klaus H Kaestner; Kevin K Ohlemiller; John S Oghalai; Hannie Kremer; Benjamin L Prosser; Douglas J Epstein Journal: Dev Cell Date: 2021-05-07 Impact factor: 12.270
Authors: Heiko Locher; John C M J de Groot; Liesbeth van Iperen; Margriet A Huisman; Johan H M Frijns; Susana M Chuva de Sousa Lopes Journal: Dev Neurobiol Date: 2015-02-28 Impact factor: 3.964
Authors: Eveline P de Jong; Herma C Holscher; Sylke J Steggerda; Jeanine M M Van Klink; Erika P M van Elzakker; Enrico Lopriore; Frans J Walther; Frank Brus Journal: Eur J Pediatr Date: 2017-09-10 Impact factor: 3.183